Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Mundipharma Research GmbH & Co KG |
---|---|
Information provided by: | Mundipharma Research GmbH & Co KG |
ClinicalTrials.gov Identifier: | NCT00412152 |
The primary objective of this study is to demonstrate that subjects with moderate to severe non-malignant pain taking oxycodone/naloxone prolonged release tablets have improvement in symptoms of constipation compared to subjects taking oxycodone prolonged release tablets alone.
Condition | Intervention | Phase |
---|---|---|
Pain |
Drug: Oxycodone nalaxone prolonged release tablets (OXN) |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Randomised, Double-Blind, Parallel-Group, Multicentre Study to Demonstrate Improvement in Symptoms of Constipation in Subjects With Non-Malignant Pain Taking Oxycodone Equivalent of >20 mg/Day and <50 mg/Day as Oxycodone/Naloxone Prolonged Release Compared to Subjects Taking Oxycodone Prolonged Release Tablets Alone. |
Study Start Date: | January 2006 |
Estimated Study Completion Date: | April 2008 |
Patients with a documented history of moderate to severe non-malignant pain that require around the clock opioid therapy will be randomised to an oxycodone or an oxycodone-naloxone treatment arm to assess the safety and efficacy of oxycodone/naloxone prolonged release compared to oxycodone prolonged-release in relieving opioid-related constipation.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | OXN3001, 2005-002398-57 |
Study First Received: | December 14, 2006 |
Last Updated: | April 29, 2008 |
ClinicalTrials.gov Identifier: | NCT00412152 |
Health Authority: | United Kingdom: Research Ethics Committee |
A randomised double blind parallel group multicentre study to demonstrate improvement in symptoms of constipation in subjects with non malignant pain Moderate to severe chronic non-malignant pain |
Signs and Symptoms Signs and Symptoms, Digestive Oxycodone |
Constipation Pain Naloxone |
Sensory System Agents Therapeutic Uses Physiological Effects of Drugs Central Nervous System Depressants Narcotics |
Peripheral Nervous System Agents Analgesics Central Nervous System Agents Analgesics, Opioid Pharmacologic Actions |